시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
생물학적 안전성 시험 시장 규모, 점유율, 성장 분석 : 제품 및 서비스별, 시험 유형별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Biologics Safety Testing Market Size, Share, and Growth Analysis, By Product and Services (Consumables, Instruments), By Test Type (Endotoxin tests, Sterility tests), By Application, By End User, By Region - Industry Forecast 2025-2032
상품코드 : 1663872
리서치사 : SkyQuest
발행일 : 2025년 02월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,652,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,951,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,250,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

생물학적 안전성 시험 2023년 시장 규모는 52억 5,000만 달러로 평가되며, 2024년 58억 6,000만 달러에서 2032년 142억 1,000만 달러로 예측 기간(2025-2032년) 동안 11.7%의 CAGR로 성장할 것으로 예상됩니다.

생물학적 안전성 시험은 생물학적 공급원으로부터 유래한 바이오의약품 및 의료기기의 안전성 확보에 초점을 맞춘 필수적인 프로세스입니다. 이 종합적인 접근 방식은 오염 및 생물학적 부작용을 분석하여 잠재적 위험을 평가하고 완화하는 것을 목표로 합니다. 엄격한 규제 기준을 준수하는 것은 이러한 물질의 순도, 역가 및 전반적인 안전성을 확인하는 데 매우 중요합니다. 무균 시험, 내독소 평가, 세포 기반 분석과 같은 주요 기술은 엄격한 안전성 벤치마크를 준수하는지 평가하는 데 중요한 역할을 합니다. 안전하고 효과적인 의료 제품에 대한 수요가 증가함에 따라 생물학적 안전성 시험 시장은 규제 요건의 증가와 공중 보건 및 환자 안전에 대한 관심 증가에 힘입어 확대되고 있습니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

생물학적 안전성 시험 시장 규모 : 제품 및 서비스별 & CAGR(2025-2032년)

생물학적 안전성 시험 시장 규모 : 시험 유형별 & CAGR(2025-2032년)

생물학적 안전성 시험 시장 규모 : 용도별 & CAGR(2025-2032년)

생물학적 안전성 시험 시장 규모 : 최종사용자별 & CAGR(2025-2032년)

생물학적 안전성 시험 시장 규모 : 지역별 & CAGR(2025-2032년)

경쟁 정보

주요 기업 개요

결론과 제안

ksm
영문 목차

영문목차

Biologics Safety Testing Market size was valued at USD 5.25 billion in 2023 and is poised to grow from USD 5.86 billion in 2024 to USD 14.21 billion by 2032, growing at a CAGR of 11.7% during the forecast period (2025-2032).

Biological safety testing is an essential process focused on ensuring the safety of biopharmaceuticals and medical devices derived from biological sources. This comprehensive approach aims to assess and mitigate potential risks by analyzing contamination and adverse biological effects. Adhering to stringent regulatory standards is crucial for confirming the purity, potency, and overall safety of these materials. Key techniques, including sterility testing, endotoxin assessment, and cell-based assays, play vital roles in evaluating compliance with rigorous safety benchmarks. As the demand for safe and effective medical products grows, the biological safety testing market is poised for expansion, driven by increasing regulatory requirements and a heightened focus on public health and patient safety.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biologics Safety Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biologics Safety Testing Market Segments Analysis

Global Biologics Safety Testing Market is segmented by Product and Services, Test Type, Application, End User and region. Based on Product and Services, the market is segmented into Consumables, Instruments, Services, Reagents and kits and Other Biologics Safety Testing Services. Based on Test Type, the market is segmented into Endotoxin tests, Sterility tests, Mycoplasma tests, Bioburden tests, Residual host-cell proteins and DNA detection tests, Virus safety tests, Adventitious agent detection tests and Other test types. Based on Application, the market is segmented into Monoclonal Antibodies Development And Manufacturing, Vaccines Development And Manufacturing, Cellular & Gene Therapy Products Development And Manufacturing, Blood & Blood Products Development And Manufacturing and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Cros & Cdmos and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biologics Safety Testing Market

Recent expansions in the pharmaceutical and biotechnology sectors, driven by significant investments in research and development, mark a critical phase in the evolution of healthcare. These industries are at the leading edge of developing pharmaceuticals, biologics, and vaccines, effectively tackling complex healthcare challenges, particularly in the fight against intricate diseases. This wave of innovation inherently heightens the demand for rigorous safety assessments, where biologics safety testing becomes essential in ensuring patient safety. As the landscape of healthcare continues to evolve, the importance of robust safety testing mechanisms will become increasingly vital in maintaining public health standards and fostering trust in new therapeutic solutions.

Restraints in the Biologics Safety Testing Market

The Biologics Safety Testing market faces several challenges that may hinder its growth. Key restraints include stringent regulatory requirements that can complicate the testing processes, alongside the high costs associated with developing and maintaining testing protocols. Furthermore, the constantly evolving landscape of biologics, coupled with the rapid advancement of biotechnology, necessitates ongoing updates in testing methodologies, which can be resource-intensive. Additionally, the limited availability of skilled professionals in the field may impede market expansion. These factors create significant hurdles for stakeholders aiming to navigate the complexities of biologics safety testing, ultimately affecting their ability to innovate and maintain compliance.

Market Trends of the Biologics Safety Testing Market

The Biologics Safety Testing market is experiencing significant growth, driven by intensified regulatory scrutiny on biopharmaceutical products, which emphasizes patient safety and product quality. As global regulatory bodies enforce stringent safety evaluations, biological safety testing has become essential for drug approvals, compelling pharmaceutical and biotech companies to prioritize compliance. This shift not only underscores the importance of comprehensive safety assessments but also stimulates heightened demand for specialized testing services. Consequently, the market is solidifying its position as a critical component in pharmaceutical development, ensuring that companies can navigate the complexities of regulatory requirements and achieve timely market entry.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Biologics Safety Testing Market Size by Product and Services & CAGR (2025-2032)

Global Biologics Safety Testing Market Size by Test Type & CAGR (2025-2032)

Global Biologics Safety Testing Market Size by Application & CAGR (2025-2032)

Global Biologics Safety Testing Market Size by End User & CAGR (2025-2032)

Global Biologics Safety Testing Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기